APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyanocobalamin Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cyanocobalamin Injection Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchCyanocobalamin Injection Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyanocobalamin Injection Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Cyanocobalamin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyanocobalamin Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyanocobalamin Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cyanocobalamin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cyanocobalamin Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cyanocobalamin Injection market include ANGELINI, Bayer HealthCare, Biological E, Bristol-Myers Squibb, CCEPCD, Endo International, Huaxin Pharmaceutical, Jamieson and Luitpold Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyanocobalamin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyanocobalamin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyanocobalamin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyanocobalamin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyanocobalamin Injection Segment by Company

ANGELINI

Bayer HealthCare

Biological E

Bristol-Myers Squibb

CCEPCD

Endo International

Huaxin Pharmaceutical

Jamieson

Luitpold Pharmaceuticals

Luitpold Pharmaceuticals (Daiichi Sankyo)

Sanofi-Aventis

Pfizer

Mylan

Merck

Teva (Actavis)

Cyanocobalamin Injection Segment by Type

Vitamins

Supplements

Cyanocobalamin Injection Segment by Application

Hospitals

Clinics

Others

Cyanocobalamin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cyanocobalamin Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cyanocobalamin Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cyanocobalamin Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Cyanocobalamin Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyanocobalamin Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyanocobalamin Injection industry.

Chapter 3: Detailed analysis of Cyanocobalamin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cyanocobalamin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cyanocobalamin Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cyanocobalamin Injection Industry Trends Table 2. Cyanocobalamin Injection Industry Drivers Table 3. Cyanocobalamin Injection Industry Opportunities and Challenges Table 4. Cyanocobalamin Injection Industry Restraints Table 5. Global Cyanocobalamin Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cyanocobalamin Injection Revenue Share by Company (2021-2026) Table 7. Global Cyanocobalamin Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Cyanocobalamin Injection Sales Volume Share by Company (2021-2026) Table 9. Global Cyanocobalamin Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Cyanocobalamin Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cyanocobalamin Injection Key Company Manufacturing Base & Headquarters Table 12. Global Cyanocobalamin Injection Company, Product Type & Application Table 13. Global Cyanocobalamin Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyanocobalamin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vitamins Table 18. Significant Companies of Supplements Table 19. Global Cyanocobalamin Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Cyanocobalamin Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Cyanocobalamin Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Cyanocobalamin Injection Sales Volume Share by Type (2021-2026) Table 23. Global Cyanocobalamin Injection Sales Volume Share by Type (2027-2032) Table 24. Global Cyanocobalamin Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cyanocobalamin Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cyanocobalamin Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cyanocobalamin Injection Sales Value Share by Type (2021-2026) Table 28. Global Cyanocobalamin Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Cyanocobalamin Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Cyanocobalamin Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Cyanocobalamin Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Cyanocobalamin Injection Sales Volume Share by Application (2021-2026) Table 36. Global Cyanocobalamin Injection Sales Volume Share by Application (2027-2032) Table 37. Global Cyanocobalamin Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cyanocobalamin Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Cyanocobalamin Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Cyanocobalamin Injection Sales Value Share by Application (2021-2026) Table 41. Global Cyanocobalamin Injection Sales Value Share by Application (2027-2032) Table 42. Global Cyanocobalamin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Cyanocobalamin Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Cyanocobalamin Injection Sales Market Share by Region (2021-2026) Table 45. Global Cyanocobalamin Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Cyanocobalamin Injection Sales Market Share by Region (2027-2032) Table 47. Global Cyanocobalamin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Cyanocobalamin Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Cyanocobalamin Injection Sales Value Share by Region (2021-2026) Table 50. Global Cyanocobalamin Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Cyanocobalamin Injection Sales Value Share by Region (2027-2032) Table 52. Global Cyanocobalamin Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Cyanocobalamin Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Cyanocobalamin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Cyanocobalamin Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Cyanocobalamin Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Cyanocobalamin Injection Sales Market Share by Country (2021-2026) Table 58. Global Cyanocobalamin Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Cyanocobalamin Injection Sales Market Share by Country (2027-2032) Table 60. Global Cyanocobalamin Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Cyanocobalamin Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Cyanocobalamin Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Cyanocobalamin Injection Sales Value Market Share by Country (2027-2032) Table 64. ANGELINI Company Information Table 65. ANGELINI Business Overview Table 66. ANGELINI Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. ANGELINI Cyanocobalamin Injection Product Portfolio Table 68. ANGELINI Recent Development Table 69. Bayer HealthCare Company Information Table 70. Bayer HealthCare Business Overview Table 71. Bayer HealthCare Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bayer HealthCare Cyanocobalamin Injection Product Portfolio Table 73. Bayer HealthCare Recent Development Table 74. Biological E Company Information Table 75. Biological E Business Overview Table 76. Biological E Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biological E Cyanocobalamin Injection Product Portfolio Table 78. Biological E Recent Development Table 79. Bristol-Myers Squibb Company Information Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio Table 83. Bristol-Myers Squibb Recent Development Table 84. CCEPCD Company Information Table 85. CCEPCD Business Overview Table 86. CCEPCD Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. CCEPCD Cyanocobalamin Injection Product Portfolio Table 88. CCEPCD Recent Development Table 89. Endo International Company Information Table 90. Endo International Business Overview Table 91. Endo International Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Endo International Cyanocobalamin Injection Product Portfolio Table 93. Endo International Recent Development Table 94. Huaxin Pharmaceutical Company Information Table 95. Huaxin Pharmaceutical Business Overview Table 96. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio Table 98. Huaxin Pharmaceutical Recent Development Table 99. Jamieson Company Information Table 100. Jamieson Business Overview Table 101. Jamieson Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jamieson Cyanocobalamin Injection Product Portfolio Table 103. Jamieson Recent Development Table 104. Luitpold Pharmaceuticals Company Information Table 105. Luitpold Pharmaceuticals Business Overview Table 106. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio Table 108. Luitpold Pharmaceuticals Recent Development Table 109. Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information Table 110. Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview Table 111. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio Table 113. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development Table 114. Sanofi-Aventis Company Information Table 115. Sanofi-Aventis Business Overview Table 116. Sanofi-Aventis Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sanofi-Aventis Cyanocobalamin Injection Product Portfolio Table 118. Sanofi-Aventis Recent Development Table 119. Pfizer Company Information Table 120. Pfizer Business Overview Table 121. Pfizer Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Pfizer Cyanocobalamin Injection Product Portfolio Table 123. Pfizer Recent Development Table 124. Mylan Company Information Table 125. Mylan Business Overview Table 126. Mylan Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Mylan Cyanocobalamin Injection Product Portfolio Table 128. Mylan Recent Development Table 129. Merck Company Information Table 130. Merck Business Overview Table 131. Merck Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Merck Cyanocobalamin Injection Product Portfolio Table 133. Merck Recent Development Table 134. Teva (Actavis) Company Information Table 135. Teva (Actavis) Business Overview Table 136. Teva (Actavis) Cyanocobalamin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Teva (Actavis) Cyanocobalamin Injection Product Portfolio Table 138. Teva (Actavis) Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Cyanocobalamin Injection Distributors List Table 142. Cyanocobalamin Injection Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Cyanocobalamin Injection Product Image Figure 2. Global Cyanocobalamin Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyanocobalamin Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cyanocobalamin Injection Sales (2021-2032) & (K Units) Figure 5. Global Cyanocobalamin Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Cyanocobalamin Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vitamins Image Figure 10. Supplements Image Figure 11. Global Cyanocobalamin Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Cyanocobalamin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cyanocobalamin Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Cyanocobalamin Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cyanocobalamin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cyanocobalamin Injection Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Cyanocobalamin Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Cyanocobalamin Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Cyanocobalamin Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Cyanocobalamin Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cyanocobalamin Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Cyanocobalamin Injection Sales Value Share by Application (2021-2032) Figure 26. Global Cyanocobalamin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Cyanocobalamin Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Cyanocobalamin Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Cyanocobalamin Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Cyanocobalamin Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Cyanocobalamin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Cyanocobalamin Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Cyanocobalamin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Cyanocobalamin Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cyanocobalamin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Cyanocobalamin Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Cyanocobalamin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Cyanocobalamin Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Cyanocobalamin Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Cyanocobalamin Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Cyanocobalamin Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Cyanocobalamin Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamins
  • Supplements
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • ANGELINI
  • Bayer HealthCare
  • Biological E
  • Bristol-Myers Squibb
  • CCEPCD
  • Endo International
  • Huaxin Pharmaceutical
  • Jamieson
  • Luitpold Pharmaceuticals
  • Luitpold Pharmaceuticals (Daiichi Sankyo)
  • Sanofi-Aventis
  • Pfizer
  • Mylan
  • Merck
  • Teva (Actavis)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyanocobalamin Injection Sales Value (2021-2032)
  4. 1.2.2 Global Cyanocobalamin Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Cyanocobalamin Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cyanocobalamin Injection Market Dynamics
  1. 2.1 Cyanocobalamin Injection Industry Trends
  2. 2.2 Cyanocobalamin Injection Industry Drivers
  3. 2.3 Cyanocobalamin Injection Industry Opportunities and Challenges
  4. 2.4 Cyanocobalamin Injection Industry Restraints
3 Cyanocobalamin Injection Market by Company
  1. 3.1 Global Cyanocobalamin Injection Company Revenue Ranking in 2025
  2. 3.2 Global Cyanocobalamin Injection Revenue by Company (2021-2026)
  3. 3.3 Global Cyanocobalamin Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Cyanocobalamin Injection Average Price by Company (2021-2026)
  5. 3.5 Global Cyanocobalamin Injection Company Ranking (2024-2026)
  6. 3.6 Global Cyanocobalamin Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Cyanocobalamin Injection Company Product Type and Application
  8. 3.8 Global Cyanocobalamin Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cyanocobalamin Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cyanocobalamin Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cyanocobalamin Injection Market by Type
  1. 4.1 Cyanocobalamin Injection Type Introduction
  2. 4.1.1 Vitamins
  3. 4.1.2 Supplements
  4. 4.2 Global Cyanocobalamin Injection Sales Volume by Type
  5. 4.2.1 Global Cyanocobalamin Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyanocobalamin Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cyanocobalamin Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cyanocobalamin Injection Sales Value by Type
  9. 4.3.1 Global Cyanocobalamin Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyanocobalamin Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cyanocobalamin Injection Sales Value Share by Type (2021-2032)
5 Cyanocobalamin Injection Market by Application
  1. 5.1 Cyanocobalamin Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Cyanocobalamin Injection Sales Volume by Application
  6. 5.2.1 Global Cyanocobalamin Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyanocobalamin Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cyanocobalamin Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cyanocobalamin Injection Sales Value by Application
  10. 5.3.1 Global Cyanocobalamin Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyanocobalamin Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cyanocobalamin Injection Sales Value Share by Application (2021-2032)
6 Cyanocobalamin Injection Regional Sales and Value Analysis
  1. 6.1 Global Cyanocobalamin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyanocobalamin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cyanocobalamin Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Cyanocobalamin Injection Sales by Region (2027-2032)
  5. 6.3 Global Cyanocobalamin Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cyanocobalamin Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cyanocobalamin Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cyanocobalamin Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Cyanocobalamin Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cyanocobalamin Injection Sales Value (2021-2032)
  12. 6.6.2 North America Cyanocobalamin Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cyanocobalamin Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Cyanocobalamin Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cyanocobalamin Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cyanocobalamin Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cyanocobalamin Injection Sales Value (2021-2032)
  21. 6.9.2 South America Cyanocobalamin Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cyanocobalamin Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cyanocobalamin Injection Sales Value Share by Country, 2025 VS 2032
7 Cyanocobalamin Injection Country-level Sales and Value Analysis
  1. 7.1 Global Cyanocobalamin Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cyanocobalamin Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cyanocobalamin Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Cyanocobalamin Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Cyanocobalamin Injection Sales by Country (2027-2032)
  6. 7.4 Global Cyanocobalamin Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cyanocobalamin Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cyanocobalamin Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cyanocobalamin Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cyanocobalamin Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cyanocobalamin Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ANGELINI
  2. 8.1.1 ANGELINI Company Information
  3. 8.1.2 ANGELINI Business Overview
  4. 8.1.3 ANGELINI Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ANGELINI Cyanocobalamin Injection Product Portfolio
  6. 8.1.5 ANGELINI Recent Developments
  7. 8.2 Bayer HealthCare
  8. 8.2.1 Bayer HealthCare Company Information
  9. 8.2.2 Bayer HealthCare Business Overview
  10. 8.2.3 Bayer HealthCare Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare Cyanocobalamin Injection Product Portfolio
  12. 8.2.5 Bayer HealthCare Recent Developments
  13. 8.3 Biological E
  14. 8.3.1 Biological E Company Information
  15. 8.3.2 Biological E Business Overview
  16. 8.3.3 Biological E Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biological E Cyanocobalamin Injection Product Portfolio
  18. 8.3.5 Biological E Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 CCEPCD
  26. 8.5.1 CCEPCD Company Information
  27. 8.5.2 CCEPCD Business Overview
  28. 8.5.3 CCEPCD Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CCEPCD Cyanocobalamin Injection Product Portfolio
  30. 8.5.5 CCEPCD Recent Developments
  31. 8.6 Endo International
  32. 8.6.1 Endo International Company Information
  33. 8.6.2 Endo International Business Overview
  34. 8.6.3 Endo International Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Endo International Cyanocobalamin Injection Product Portfolio
  36. 8.6.5 Endo International Recent Developments
  37. 8.7 Huaxin Pharmaceutical
  38. 8.7.1 Huaxin Pharmaceutical Company Information
  39. 8.7.2 Huaxin Pharmaceutical Business Overview
  40. 8.7.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio
  42. 8.7.5 Huaxin Pharmaceutical Recent Developments
  43. 8.8 Jamieson
  44. 8.8.1 Jamieson Company Information
  45. 8.8.2 Jamieson Business Overview
  46. 8.8.3 Jamieson Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jamieson Cyanocobalamin Injection Product Portfolio
  48. 8.8.5 Jamieson Recent Developments
  49. 8.9 Luitpold Pharmaceuticals
  50. 8.9.1 Luitpold Pharmaceuticals Company Information
  51. 8.9.2 Luitpold Pharmaceuticals Business Overview
  52. 8.9.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio
  54. 8.9.5 Luitpold Pharmaceuticals Recent Developments
  55. 8.10 Luitpold Pharmaceuticals (Daiichi Sankyo)
  56. 8.10.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
  57. 8.10.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview
  58. 8.10.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio
  60. 8.10.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Developments
  61. 8.11 Sanofi-Aventis
  62. 8.11.1 Sanofi-Aventis Company Information
  63. 8.11.2 Sanofi-Aventis Business Overview
  64. 8.11.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi-Aventis Cyanocobalamin Injection Product Portfolio
  66. 8.11.5 Sanofi-Aventis Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Cyanocobalamin Injection Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Cyanocobalamin Injection Product Portfolio
  78. 8.13.5 Mylan Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Merck Cyanocobalamin Injection Product Portfolio
  84. 8.14.5 Merck Recent Developments
  85. 8.15 Teva (Actavis)
  86. 8.15.1 Teva (Actavis) Company Information
  87. 8.15.2 Teva (Actavis) Business Overview
  88. 8.15.3 Teva (Actavis) Cyanocobalamin Injection Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Teva (Actavis) Cyanocobalamin Injection Product Portfolio
  90. 8.15.5 Teva (Actavis) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyanocobalamin Injection Value Chain Analysis
  2. 9.1.1 Cyanocobalamin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyanocobalamin Injection Sales Mode & Process
  6. 9.2 Cyanocobalamin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyanocobalamin Injection Distributors
  9. 9.2.3 Cyanocobalamin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst